Devonian Health Group Inc. (TSXV:GSD)
Canada · Delayed Price · Currency is CAD 9.75
-1.25 (-11.36%)
At close: Aug 28, 2026
Devonian Health Group Income Statement
Financials in millions CAD. Fiscal year is August - July.
Millions CAD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
| 3 | 23.59 | 19.31 | 2.35 | 2.31 | 1.47 | |
Revenue Growth | -90.77% | 22.19% | 723.15% | 1.74% | 56.32% | -31.19% |
Cost of Revenue | 0.96 | 15.03 | 11.83 | 1.45 | 1.74 | 1.72 |
Gross Profit | 2.03 | 8.56 | 7.48 | 0.89 | 0.56 | -0.24 |
Selling, General & Admin | 6.66 | 7.2 | 6.68 | 3.75 | 2.58 | 1.45 |
Research & Development | 1.43 | 2.01 | 1.29 | 1.35 | 0.78 | 0.61 |
Other Operating Expenses | 0.13 | 0.13 | 0.12 | 0.12 | 0.11 | - |
Operating Expenses | 8.22 | 9.33 | 8.09 | 5.22 | 3.47 | 2.07 |
Operating Income | -6.19 | -0.77 | -0.61 | -4.32 | -2.91 | -2.31 |
Interest Expense | -0.04 | -0.26 | -0.44 | -0.46 | -0.94 | -0.79 |
Interest & Investment Income | 0.11 | 0.28 | 0.07 | 0.18 | 0.04 | - |
Other Non Operating Income (Expenses) | - | - | - | - | 0.36 | -0.29 |
EBT Excluding Unusual Items | -6.13 | -0.75 | -0.98 | -4.6 | -3.45 | -3.39 |
Impairment of Goodwill | - | -4.64 | - | - | - | - |
Asset Writedown | - | -0.2 | - | - | - | - |
Other Unusual Items | - | - | - | - | - | 0.05 |
Pretax Income | -6.13 | -5.59 | -0.98 | -4.6 | -3.45 | -3.35 |
Income Tax Expense | -0.01 | 0.42 | 0.85 | - | - | - |
Net Income | -6.11 | -6.01 | -1.83 | -4.6 | -3.45 | -3.35 |
Net Income to Common | -6.11 | -6.01 | -1.83 | -4.6 | -3.45 | -3.35 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 3 | 2 | 2 | 2 | 2 | 1 |
Shares Outstanding (Diluted) | 3 | 2 | 2 | 2 | 2 | 1 |
Shares Change | 9.29% | 0.76% | 8.52% | 13.89% | 33.98% | 22.70% |
EPS (Basic) | -2.26 | -2.43 | -0.75 | -2.04 | -1.74 | -2.26 |
EPS (Diluted) | -2.26 | -2.43 | -0.75 | -2.04 | -1.74 | -2.28 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Jul '25 Jul 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 |
Free Cash Flow | -11.77 | -1.27 | 5.64 | -4.36 | -2.95 | -1.83 |
Free Cash Flow Per Share | -4.36 | -0.51 | 2.30 | -1.93 | -1.49 | -1.24 |
Gross Margin | 67.89% | 36.28% | 38.74% | 38.05% | 24.34% | -16.34% |
Operating Margin | -206.69% | -3.27% | -3.18% | -184.37% | -126.35% | -156.37% |
Profit Margin | -204.08% | -25.49% | -9.46% | -196.11% | -149.59% | -226.92% |
Free Cash Flow Margin | -393.06% | -5.36% | 29.20% | -185.74% | -127.77% | -124.31% |
EBITDA | -5.92 | -0.47 | -0.22 | -3.92 | -2.07 | -1.3 |
EBITDA Margin | -197.67% | -1.99% | -1.14% | -167.35% | -89.81% | -87.87% |
D&A For EBITDA | 0.27 | 0.3 | 0.39 | 0.4 | 0.84 | 1.01 |
EBIT | -6.19 | -0.77 | -0.61 | -4.32 | -2.91 | -2.31 |
EBIT Margin | -206.69% | -3.27% | -3.18% | -184.37% | -126.35% | -156.37% |